NCT03484494 Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression Status ACTIVE_NOT_RECRUITING Phase NA
NCT03292848 Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders Status COMPLETED Phase PHASE1
NCT03287869 A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder. Status COMPLETED Phase PHASE3
NCT03259555 A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT03257865 A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT03201757 Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 Status COMPLETED Phase PHASE3
NCT03192631 Financial Incentives to Improve Acceptance of Antipsychotic Injections Status UNKNOWN Phase NA
NCT03187769 Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT03156504 The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression. Status COMPLETED Phase PHASE4
NCT02722967 Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System Status COMPLETED Phase PHASE2
NCT02593643 Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression. Status COMPLETED Phase EARLY_PHASE1
NCT01998516 Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder Status COMPLETED Phase N/A
NCT01986114 A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder. Status COMPLETED Phase PHASE3
NCT01977300 Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode Status COMPLETED Phase PHASE3
NCT01828931 Lifestyle Intervention for Diabetes and Weight Management in Psychosis Status COMPLETED Phase NA
NCT01825837 Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate in the Recurrence Prevention of Bipolar I Disorder Status COMPLETED Phase PHASE2